Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -1.28% vs -1.64% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -28.00% vs 153.53% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -27.43% vs 111.63% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -9.09% vs -50.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Mayinglong Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -1.28% vs -1.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.83% vs 0.33% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -28.00% vs 153.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 7.20% vs 22.34% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -27.43% vs 111.63% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 7.70% vs 14.79% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -9.09% vs -50.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -54.55% vs -26.67% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






